Holen Sie sich die Stockscreener-App
86.79
0.81%
0.70
Vorhandelsmarkt:
86.35
-0.44
-0.51%
Schlusskurs vom Vortag:
$86.09
Offen:
$86.23
24-Stunden-Volumen:
137.26K
Relative Volume:
0.40
Marktkapitalisierung:
$907.13M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+3.35%
1M Leistung:
-4.61%
6M Leistung:
-5.81%
1J Leistung:
+0.31%
1-Tages-Spanne:
$85.20
$86.88
1-Wochen-Bereich:
$82.58
$86.88
52-Wochen-Spanne:
$77.67
$99.51
Vaneck Pharmaceutical Etf Stock (PPH) Company Profile
Firmenname
Vaneck Pharmaceutical Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PPH
Vaneck Pharmaceutical Etf
|
86.79 | 907.13M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
270.64 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
550.64 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
553.19 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
214.78 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
472.56 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Pharmaceutical Etf Aktie (PPH) Neueste Nachrichten
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Bought by JPMorgan Chase & Co. - Defense World
Where to Invest $10,000 Right Now - Bloomberg.com
VanEck Pharmaceutical ETF Target of Unusually High Options Trading (NASDAQ:PPH) - Defense World
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - Nasdaq
ETFs in Focus Post JNJ's Q1 Earnings Beat, Dividend Hike - TradingView
Trump says pharma tariffs are coming in the “not-too-distant-future” - Seeking Alpha
PPH: Will Overcome Tariffs, But Competitor Funds Look Stronger (NASDAQ:PPH) - Seeking Alpha
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies - Benzinga
Pharma, MedTech stocks bounce back as Trump pauses most tariffs - Seeking Alpha
LPL Financial LLC Sells 35,154 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Trump says 'major tariff on pharmaceuticals' coming soon (PPH:NASDAQ) - Seeking Alpha
StockWatch: Biopharma Funds Tumble with Wall Street as Industry Spared from Worst of Tariffs—for Now - Genetic Engineering and Biotechnology News
Big Pharma higher after tariff exemption despite ongoing uncertainties - MSN
Raymond James Financial Inc. Invests $1.32 Million in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Big Pharma drops sharply ahead of Trump’s tariff announcement - MSN
Top Semiconductor Companies to Watch in 2025 - VanEck
U.S. Consumers To Be Hit Hardest By Pharmaceutical Tariffs - Seeking Alpha
Commonwealth Equity Services LLC Buys 631 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo Finance
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by US Bancorp DE - Defense World
Assetmark Inc. Has $86,000 Stock Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
SBI Securities Co. Ltd. Makes New Investment in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Jones Financial Companies Lllp Acquires 5,408 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - Yahoo Finance
AI-Driven Semiconductor Growth - VanEck
Atria Wealth Solutions Inc. Has $304,000 Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Novartis pulls back after report on Emasan share offering - MSN
A Better Way to Equal Weight? - VanEck
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - MSN
First Trust Nyse Arca Biotech Etf (FBT) - INDmoney
Trade War Redux: These ETFs Due For Bumpy Ride Thanks To Trump Tariffs On Auto, Pharma, Chip Imports - Benzinga
Cencora Stock Outlook: Is Wall Street Bullish or Bearish? - TradingView
Five ETFs to invest in to hedge against policy uncertainty in 2025 - TradingView
DeepSeek’s Disruption: The Impact on Nvidia and the Semiconductor Industry - VanEck
How to profit from AI innovation in 2025 - Equities News
Is Wall Street Bullish or Bearish on AbbVie Stock? - Inkl
2025 Semiconductor Outlook: Investor Roadmap - VanEck
JPMorgan Chase & Co. Has $907,000 Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Barclays PLC Sells 3,263 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Is Investing in the WisdomTree Cloud Computing ETF (WCLD) a Smart Move - espeaks.co.uk
Gold in 2024: Central Bank Demand, Rising Prices and the Equity Disconnect - VanEck
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip - MSN
Is Investing in the Invesco Semiconductors ETF (PSI) a Smart Move - espeaks.co.uk
Finanzdaten der Vaneck Pharmaceutical Etf-Aktie (PPH)
Es liegen keine Finanzdaten für Vaneck Pharmaceutical Etf (PPH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.20%
1.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):